Dare Bioscience
DARE
38 hedge funds and large institutions have $45.4M invested in Dare Bioscience in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 5 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
22% less capital invested
Capital invested by funds: $58.6M → $45.4M (-$13.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$320K |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$189K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$89K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$87K |
| 5 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
+$83.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$1.27M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$477K |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$395K |
| 4 |
Millennium Management
New York
|
-$126K |
| 5 |
Goldman Sachs
New York
|
-$96K |
DARE Hedge Fund Activity: Q3 2015 in Review
38 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2015, worth a combined $45.4M — down 22% from $58.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DARE positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $320K. The largest seller was Clough Capital Partners, exiting entirely with an estimated $1.27M sold.
- 38 institutional investors held Dare Bioscience (DARE) as of Q3 2015, up from 37 in Q2 2015.
- Funds reported $45.4M of Dare Bioscience stock for Q3 2015, down 22% quarter-over-quarter.
- 6 funds opened new Dare Bioscience positions in Q3 2015 and 5 closed out, a net change of +1 holder.
- The largest Dare Bioscience buyer in Q3 2015 was Vanguard Group, an estimated $320K added.
- The largest Dare Bioscience seller in Q3 2015 was Clough Capital Partners, an estimated $1.27M sold.
Based on aggregated 13F filings for Q3 2015.